Attenuation of MicroRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy

30-Year Trends in Heart Failure in Patients Hospitalized With Acute Myocardial Infarction

(2011) David D. McManus et al.   AMERICAN JOURNAL OF CARDIOLOGY

Antihypertensive Treatment and Development of Heart Failure in Hypertension

(2010) Sebastiano Sciarretta et al.   ARCHIVES OF INTERNAL MEDICINE

MicroRNA, Emerging Role as a Biomarker of Heart Failure

(2010) Tsuneaki Kawashima et al.   CIRCULATION JOURNAL

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans

(2010) Guo-Kun Wang et al.   EUROPEAN HEART JOURNAL

Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic function

(2010) Barak Zafrir et al.   European Journal of Internal Medicine

MicroRNA-21 protects neurons from ischemic death

(2010) Ben Buller et al.   FEBS Journal

Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy

(2010) Yang Ye et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

miR-9 and NFATc3 Regulate Myocardin in Cardiac Hypertrophy

(2010) Kun Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy

(2010) Q. Li et al.   JOURNAL OF CELL SCIENCE

MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes

(2010) Xiao-Wei Song et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin–angiotensin system

(2010) A.S.R. Araujo et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics

(2010) Nadav Bar et al.   PLoS One

Cardiac regulation by phosphoinositide 3-kinases and PTEN

(2009) G. Y. Oudit et al.   CARDIOVASCULAR RESEARCH

Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry

(2009) G. Boriani et al.   EUROPEAN HEART JOURNAL

Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population

(2009) Jing Xu et al.   HUMAN MUTATION

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice

(2009) Thomas E. Callis et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy

(2009) Z. Lin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling

(2008) Paula A. da Costa Martins et al.   CIRCULATION

The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure

(2008) Vijay Divakaran et al.   CIRCULATION RESEARCH

miR-133 and miR-30 Regulate Connective Tissue Growth Factor

(2008) Rudy F. Duisters et al.   CIRCULATION RESEARCH

Myosin Regulatory Light Chain Phosphorylation Attenuates Cardiac Hypertrophy

(2008) Jian Huang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure

(2008) J.-F. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA